The Allied Forces race to secure new malaria treatments after losing access to quinine.
Date: 1943
As World War II changes the global political landscape, many countries lose access to lands in Southeast Asia where quinine is naturally harvested. New malaria treatments called quinacrine and chloroquine are developed by the German company IG Farber (later known as Bayer). This will become part of the impetus for Allied Forces to dismantle the company, which is also heavily involved in Auschwitz, after the war and rebuild it under Allied control, ensuring access to these quinine substitutes.